You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enhertu

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

Not yet recruiting
  • Her 2 Positive Breast Cancer
  • +2 more
  • Sacituzumab Govitecan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2023

Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +3 more
  • New York, New York
  • +1 more
Jul 28, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Advanced Solid Tumor, Breast Cancer Trial in Atlanta (DS-1103a, T-DXd)

Not yet recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Atlanta, Georgia
    Emory University School of Medicine
Mar 1, 2023

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab

Not yet recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 20, 2023

HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Dec 6, 2022

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)

Active, not recruiting
  • Breast Cancer Stage IV
  • Trastuzumab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
Jul 26, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Metastatic Breast Cancer, Chemo-induced Alopecia Trial in Boston (Paxman Scalp Cooling System, Eribulin, Sacituzumab govitecan)

Recruiting
  • Metastatic Breast Cancer
  • Chemotherapy-induced Alopecia
  • Paxman Scalp Cooling System
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

HER2-positive Early Breast Cancer Trial in Germany (Trastuzumab deruxtecan, Standard-of-Care)

Not yet recruiting
  • HER2-positive Early Breast Cancer
  • Munich, Bavaria, Germany
  • +11 more
Jan 19, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)

Not yet recruiting
  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • Cádiz, Andalucía, Spain
  • +18 more
Feb 24, 2023

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

Recruiting
  • Early-stage Breast Cancer
  • +6 more
  • Fullerton, California
  • +8 more
Sep 19, 2022

Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

Not yet recruiting
  • Gastrooesophageal Cancer
  • Trastuzumab deruxtecan
  • Southampton, Hampshire, United Kingdom
  • +16 more
Jul 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)

Suspended
  • Osteosarcoma
  • Recurrent Osteosarcoma
  • Trastuzumab Deruxtecan
  • Birmingham, Alabama
  • +27 more
Oct 21, 2022

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Breast Cancer, Urothelial Carcinoma Trial in Worldwide (Trastuzumab deruxtecan, Nivolumab)

Active, not recruiting
  • Breast Cancer
  • Urothelial Carcinoma
  • Santa Monica, California
  • +28 more
Aug 11, 2021

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022